Categories: News

Verisante Technology Inc. Announces Share Issuance

VANCOUVER, BC / ACCESSWIRE / June 27, 2022 / Verisante Technology Inc. (NEX:VER.H) (the “Company”) announces that further to the Company’s announcement of June 5, 2022, it has received final TSX-V Exchange acceptance and will now issue 15,154,182 pre-consolidation common shares at a deemed price of $0.05 per pre-consolidation share to settle $757,709.10 of outstanding debt. All shares issued pursuant to the Shares for Debt Transactions will be subject to a four-month-plus-one-day hold period from the date of issuance.

The Company also received exchange acceptance to issue 200,000 pre-consolidation common shares at a price of $0.05 for $10,000 pursuant to a subscription received on April 27, 2018. These transactions were suspended when the Company was subject to a Failure to File Cease Trade Order on May 4, 2018 which was revoked on April 6, 2022. All shares issued pursuant to the shares for debt and private placement will be subject to a four-month-plus-one-day hold period from the date of issuance. No finders’ fees will be paid in connection with either of the transactions. As previously announced on June 23, 2022, the Company consolidated its common shares on a 10 for 1 basis and changed its ticker symbol to “VER.H”.

The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this news release.

Company Contact:

Thomas Braun, President & CEO
Verisante Technology, Inc.
Telephone: (604) 716-5133
Email: info@verisante.com

Forward Looking Statements:

This release contains forward-looking statements all of which statements are subject to market risks, and the possibility that the Company will not be able to achieve all of its stated goals. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.

SOURCE: Verisante Technology Inc.

View source version on accesswire.com:
https://www.accesswire.com/706724/Verisante-Technology-Inc-Announces-Share-Issuance

Staff

Recent Posts

Unique Treatment for BPH, Chronic Prostatitis, Back Pain and Kidney Stones Was Unveiled at Arab Health 2024 by Ariana Adjani

* Efficacy, safety, and cost-effectiveness of Thermobalancing therapy and Dr Allen's Devices were showcased at…

19 hours ago

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

2 days ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

2 days ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

2 days ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

2 days ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

2 days ago